… treated COVID-19 patients, the reduction in the levels of NLRP3 … of the NLRP3 inflammasome
pathway to COVID-19 severity … via downregulating the NLRP3 inflammasome pathway. …

… NLRP3 inflammasome in patients with COVID-19 but not in healthy subjects. We therefore
isolated peripheral blood monocyte from patients with COVID-19 … , inflammasome activation, …

… So, we hypothesize that the pre-existing hyperactivation of NLRP3 inflammasome, …
contributing factors for the development of severe COVID-19 complications. Such patients could be …

… through facilitating the NLRP3 inflammasome activation. We … NLRP3 inflammasome through
direct interaction with NLRP3 … that NLRP3 inflammasome is a potential target for COVID-19 …

… indirect inflammasome activation and the critical role of inflammasomes in severe COVID-19. …
The NLRP3 inflammasome is known to be activated by highly pathogenic coronaviruses, …

… data show that NLRP3 inflammasome pathway activation was not different between COVID-19
and non-COVID-19 ARDS suggesting that this pathway is not COVID-19 specific and is …

… of patients with COVID‐19.Although the inflammatory basis underlying COVID‐19 fatality …
1 we suggest that an animal model based on NLRP3 inflammasome may be helpful. We are …

… NLRP3 inflammasome hyperactivity is known as a mechanism that is involved in inflammation
and cytokine storm in COVID-19… with NLRP3 inflammasome is investigated and explained. …

… Several studies have indicated that NLRP3 inflammasome activation may play a central role
… Markers of NLRP3 inflammasome activation correlate with severity of disease in Covid-19 …

… Inflammasome activation and the accompanying inflammatory response are … NLRP3
inflammasome pathway reverses chronic lung pathology. Notably, this blockade of inflammasome …